Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9years follow-up in Tehran Lipid and Glucose Study

Clinical Biochemistry

Volumn 46, Issue 9, 2013, Pages 716-721

  Tohidi, Maryam ^a   Mohebi, Reza ^a   Cheraghi, Leila ^a   Hajsheikholeslami, Farhad ^a   Aref, Saeed ^a   Nouri, Sara ^a   Azizi, Fereidoun ^a   Hadaegh, Farzad ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary heart disease; Lipid; Risk factor; Stroke

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRAN; LIPIDS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEX DISTRIBUTION; STROKE; TRIGLYCERIDES;

EID: 84877798635     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.03.012     Document Type: Article

References (39)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
2. Feigin V.L., Lawes C.M., Bennett D.A., Barker-Collo S.L., Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009, 8:355-369.
3. Azarpazhooh M.R., Etemadi M.M., Donnan G.A., Mokhber N., Majdi M.R., Ghayour-Mobarhan M., et al. Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke 2010, 41:e3-e10.
4. O'Donnell M.J., Xavier D., Liu L., Zhang H., Chin S.L., Rao-Melacini P., et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123.
5. Hadaegh F., Mohebi R., Cheraghi L., Tohidi M., Moghaddam N.B., Bozorogmanesh M., et al. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9years follow-up of the tehran lipid and glucose study. Stroke: J Cereb Circ 2012, 43:1669-1671.
6. Sharrett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sorlie P.D., Catellier D., et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2001, 104:1108-1113.
7. Lewington S., Whitlock G., Clarke R., Sherliker P., Emberson J., Halsey J., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839.
8. Canoui-Poitrine F., Luc G., Bard J.M., Ferrieres J., Yarnell J., Arveiler D., et al. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study. Cerebrovasc Dis 2010, 30:252-259.
9. Willey J.Z., Xu Q., Boden-Albala B., Paik M.C., Moon Y.P., Sacco R.L., et al. Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol 2009, 66:1400-1406.
10. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.
11. Goldstein L.B., Bushnell C.D., Adams R.J., Appel L.J., Braun L.T., Chaturvedi S., et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:517-584.
12. Azizi F., Ghanbarian A., Momenan A.A., Hadaegh F., Mirmiran P., Hedayati M., et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009, 10:5.
13. Jabbar J., Siddiqui I., Raza Q. Comparison of two methods (precipitation manual and fully automated enzymatic) for the analysis of HDL and LDL cholesterol. J Pak Med Assoc 2006, 56:59-61.
14. Okazaki M., Sasamoto K., Muramatsu T., Hosaki S. Evaluation of precipitation and direct methods for HDL-cholesterol assay by HPLC. Clin Chem 1997, 43:1885-1890.
15. Hedayati M.D.M., Azimzadeh I., Arbabi S.I. Comparison of direct method with precipitation method of HDL-cholesterol assay. J Fac Med 2007, 31:285-287.
16. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
17. Organization W.H. Cerebrovascular disorders: a clinical and research classification 1978.
18. Fahimfar N., Khalili D., Mohebi R., Azizi F., Hadaegh F. Risk factors for ischemic stroke; results from 9years of follow-up in a population based cohort of Iran. BMC Neurol 2012, 12:117.
19. Hadaegh F., Harati H., Ghanbarian A., Azizi F. Prevalence of coronary heart disease among tehran adults: Tehran lipid and glucose study. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 2009, 15:157-166.
20. Harrell F.E. Regression modeling strategies 2001, Springer, New York.
21. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
22. Zhang X., Sun Z., Zheng L., Liu S., Xu C., Li J., et al. Gender differences in blood lipids and the risk of ischemic stroke among the hypertensive adults in rural China. Neurol India 2007, 55:338-342.
23. Cui R., Iso H., Yamagishi K., Saito I., Kokubo Y., Inoue M., et al. High serum total cholesterol levels is a risk factor of ischemic stroke for general Japanese population: the JPHC study. Atherosclerosis 2012, 221:565-569.
24. Kim N.S., Ko M.M., Cha M.H., Oh S.M., Bang O.S. Age and sex dependent genetic effects of neuropeptide Y promoter polymorphism on susceptibility to ischemic stroke in Koreans. Clin Chim Acta 2010, 411:1243-1247.
25. Cuadrado-Godia E., Jimenez-Conde J., Ois A., Rodriguez-Campello A., Garcia-Ramallo E., Roquer J. Sex differences in the prognostic value of the lipid profile after the first ischemic stroke. J Neurol 2009, 256:989-995.
26. Kurth T., Everett B.M., Buring J.E., Kase C.S., Ridker P.M., Gaziano J.M. Lipid levels and the risk of ischemic stroke in women. Neurology 2007, 68:556-562.
27. Di Angelantonio E., Sarwar N., Perry P., Kaptoge S., Ray K.K., Thompson A., et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009, 302:1993-2000.
28. Horenstein R.B., Smith D.E., Mosca L. Cholesterol predicts stroke mortality in the Women's Pooling Project. Stroke 2002, 33:1863-1868.
29. Iso H., Jacobs D.R., Wentworth D., Neaton J.D., Cohen J.D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989, 320:904-910.
30. Antonios N., Angiolillo D.J., Silliman S. Hypertriglyceridemia and ischemic stroke. Eur Neurol 2008, 60:269-278.
31. Leonards C., Ebinger M., Batluk J., Malzahn U., Heuschmann P., Endres M. The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic review. Front Neurol 2010, 1:133.
32. Shahar E., Chambless L.E., Rosamond W.D., Boland L.L., Ballantyne C.M., McGovern P.G., et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003, 34:623-631.
33. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298:309-316.
34. Navab M., Berliner J.A., Subbanagounder G., Hama S., Lusis A.J., Castellani L.W., et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol 2001, 21:481-488.
35. Zabetian A., Hadaegh F., Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 2007, 77:251-257.
36. Sacco R.L., Benson R.T., Kargman D.E., Boden-Albala B., Tuck C., Lin I.F., et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 2001, 285:2729-2735.
37. Liu J., Sempos C.T., Donahue R.P., Dorn J., Trevisan M., Grundy S.M. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006, 98:1363-1368.
38. Li C., Ford E.S., Tsai J., Zhao G., Balluz L.S., Gidding S.S. Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study. Cardiovasc Diabetol 2011, 10:46.
39. Wu C.Y., Wu H.M., Lee J.D., Weng H.H. Stroke risk factors and subtypes in different age groups: a hospital-based study. Neurol India 2010, 58:863-868.